Halozyme Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $14M | 16M | 0.87 |
2023-09-30 | $8.0M | 9.5M | 0.85 |
2023-03-31 | $5.1M | 6.0M | 0.85 |